6 189

Cited 0 times in

TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease

Authors
 Ji-Hyun Lee  ;  Jong-Min Leea  ;  Eliana Marisa Ramos  ;  Tammy Gillis  ;  Jayalakshmi S. Mysore  ;  Shotaro Kishikawa  ;  Tiffany Hadzi  ;  Audrey E. Hendricks  ;  Michael R. Hayden  ;  Patrick J. Morrison  ;  Martha Nance  ;  Christopher A. Ross  ;  Russell L. Margolis  ;  Ferdinando Squitieri  ;  Cinzia Gellera  ;  Estrella Gomez-Tortosa  ;  Carmen Ayuson  ;  Oksana Suchowersky  ;  Ronald J. Trent  ;  Elizabeth McCusker  ;  Andrea Novelletto  ;  Marina Frontali  ;  Randi Jones  ;  Tetsuo Ashizawa  ;  Samuel Frank  ;  Marie-Helene Saint-Hilaire  ;  Steven M. Hersch  ;  Herminia D. Rosas  ;  Diane Lucente  ;  Madaline B. Harrison 
Citation
 Biochemical and Biophysical Research Communications, Vol.424(3) : 404-408, 2012 
Journal Title
 Biochemical and Biophysical Research Communications 
ISSN
 0006-291X 
Issue Date
2012
Abstract
Huntington's disease is a neurodegenerative disorder caused by an expanded CAG trinucleotide repeat whose length is the major determinant of age at onset but remaining variation appears to be due in part to the effect of genetic modifiers. GRIK2, which encodes GluR6, a mediator of excitatory neurotransmission in the brain, has been suggested in several studies to be a modifier gene based upon a 3' untranslated region TAA trinucleotide repeat polymorphism. Prior to investing in detailed studies of the functional impact of this polymorphism, we sought to confirm its effect on age at onset in a much larger dataset than in previous investigations. We genotyped the HD CAG repeat and the GRIK2 TAA repeat in DNA samples from 2,911 Huntington's disease subjects with known age at onset, and tested for a potential modifier effect of GRIK2 using a variety of statistical approaches. Unlike previous reports, we detected no evidence of an influence of the GRIK2 TAA repeat polymorphism on age at motor onset. Similarly, the GRIK2 polymorphism did not show significant modifier effect on psychiatric and cognitive age at onset in HD. Comprehensive analytical methods applied to a much larger sample than in previous studies do not support a role for GRIK2 as a genetic modifier of age at onset of clinical symptoms in Huntington's disease.
Full Text
http://www.sciencedirect.com/science/article/pii/S0006291X12012223
Appears in Collections:
5. Research Institutes (연구소) > Research Center for Human Natural Defense System (생체방어연구센터) > 1. Journal Papers
Yonsei Authors
이지현(Lee, Ji Hyun)
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89706
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse